Century Therapeutics, Inc. (IPSC) Shareholders’ equity 2022–2025
Century Therapeutics, Inc. (IPSC) shareholders’ equity at each fiscal year-end, per SEC filings.
$158.9MFY2025 · since FY2022: $302.7M → $158.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $158.9M | -1.5% |
| FY2024 | $161.4M | -12.7% |
| FY2023 | $184.8M | -39.0% |
| FY2022 | $302.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice